The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 27, 2019

Filed:

Oct. 06, 2015
Applicant:

Case Western Reserve University, Cleveland, OH (US);

Inventor:

Michael Weiss, Moreland Hills, OH (US);

Assignee:

Case Western Reserve University, Cleveland, OH (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/28 (2006.01); C07K 14/62 (2006.01); A61P 3/10 (2006.01); A61K 38/00 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/62 (2013.01); A61P 3/10 (2018.01); A61K 9/0019 (2013.01); A61K 38/00 (2013.01); A61K 38/28 (2013.01);
Abstract

A single-chain insulin comprises a C-domain of 6 to 11 amino acid residues comprising at least two acidic residues at the N-terminal side of the C-domain and at least two basic residues at the C-terminal side of the C-domain peptide, a basic amino acid residue at the position corresponding to A8 of human insulin, and an acidic amino acid residue at the position corresponding to A14 of human insulin. The C-domain may contain a 2 to 4 amino acid joint region between the acidic and basic residues. Residues C1 and C2 may have a net negative charge of −1 or −2; and the remaining C-domain segment may culminates with two basic residues. A pharmaceutical composition comprises the single-chain insulin, formulated at a pH within the range 7.0 to 8.0, and may be formulated at a concentration of 0.6 mM to 5.0 mM and/or at a strength of U-100 to U-1000.


Find Patent Forward Citations

Loading…